1. FDA APPROVAL SQUEEZING THE SHORTS AND RUNNING TO $28 + QUICK
2. OR A DELAY IN APPROVAL DUE TO BACKLOG OR PROBLEM WHICH WILL DROP
US A BIT UNTIL WE CAN GET BACK WITH THEM AND RESOLVE OR APPROVE
AND THEN WE STILL CLIMB
3. NON APPROVAL AND HAVE TO GO BACK AND ARGUE CASE WITH MORE TESTING
LOWERS US FOR A LONG TIME AND HAVING NO REVENUES COULD KILL US
UNLESS WE TAKE ON A PARTNER DILUTION
THE LIKELEYHOOD OF NUMBER 1 IN MY OPINION IS 90%
#2 5%
#3 5%
If we get bought out after approval which is very likely in my opinion we are looking at $40 + IMHO
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM